Gestational Trophoblastic Disease: A Closer Look at the WHO Classification
Gestational trophoblastic disease (GTD) is a diverse group of conditions that affect the placenta during pregnancy. It encompasses various tumor types that arise from abnormal placental cells. To provide a standardized framework for diagnosis and treatment, the World Health Organization (WHO) has developed a classification system for GTD. In this article, we will delve into the intricacies of the WHO classification for gestational trophoblastic disease, exploring its significance and implications.
Understanding Gestational Trophoblastic Disease:
Gestational trophoblastic disease refers to a group of conditions that involve the abnormal growth of placental cells. These conditions can occur after any type of pregnancy, including molar pregnancies, miscarriages, ectopic pregnancies, or even normal pregnancies. GTD encompasses several tumor types, including hydatidiform mole, gestational trophoblastic neoplasia, choriocarcinoma, placental site trophoblastic tumor, and epithelioid trophoblastic tumor.
The WHO Classification:
The WHO classification system is a globally recognized framework that categorizes diseases based on their characteristics, behavior, and prognosis. It provides healthcare professionals with a standardized approach to diagnose and manage diseases, ensuring consistent terminology and treatment guidelines.
In the case of gestational trophoblastic disease, the WHO classification system provides a detailed breakdown of the different tumor types and their subtypes, aiding in accurate diagnosis and appropriate management.
Hydatidiform Mole:
The WHO classification system classifies hydatidiform moles into two main subtypes: complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM). Complete moles occur when an empty egg is fertilized by a sperm, resulting in the absence of fetal tissue. Partial moles, on the other hand, occur when an egg is fertilized by two sperms, leading to an abnormal fetus with extra or missing chromosomes.
estGestational Trophoblastic Neoplasia:
Gestational trophoblastic neoplasia (GTN) refers to the malignant forms of GTD. The WHO classification system further divides GTN into four subtypes: invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). Each subtype has distinct characteristics and implications for treatment and prognosis.